The oncofetal protein, receptor tyrosine kinase-like orphan receptor 1 (ROR1), is considered as a promising target for cancer therapy due to its overexpression on many types of tumor cells with low expression in normal adult tissues [20]. This evidence concerns the gene ROR1 and neoplasm.